Field Epidemiology Training Program, National Institute of Infectious Diseases.
National Institute of Infectious Diseases.
J Epidemiol. 2024 Apr 5;34(4):187-194. doi: 10.2188/jea.JE20230025. Epub 2023 Sep 30.
Little is known about the trends of imported infectious diseases among travelers to non-endemic countries during the novel coronavirus disease 2019 (COVID-19) pandemic. This article aimed to describe those among travelers to Japan.
This is a descriptive study based on national surveillance data. Imported infectious disease cases were defined as those with a reported overseas source of infection among 15 diseases pre-selected based on the probability and impact of importation. The number of notified cases from April 2016 to March 2021 were described by disease and time of diagnosis. The relative ratio and absolute difference in case counts-both by number and per arrival-were calculated by disease comparing those from the pandemic period (April 2020-March 2021) to the pre-pandemic period (April 2016-March 2020).
A total of 3,524 imported infectious disease cases were diagnosed during the study period, including 3,439 cases before and 85 cases during the pandemic. The proportionate distribution of diseases changed but notification counts of all 15 diseases decreased during the pandemic. Accounting for arrivals, however, seven diseases showed a two-fold or greater increase, with a notable absolute increase per million arrivals for amebiasis (60.1; 95% confidence interval [CI], 41.5-78.7), malaria (21.7; 95% CI, 10.5-33.0), and typhoid fever (9.3; 95% CI, 1.9-16.8).
The epidemiology of imported infectious diseases changed during the pandemic. While the number of imported infectious disease cases decreased, the number of cases per arrivals increased considerably both in relative and absolute terms for several diseases of public health and clinical importance.
在 2019 年冠状病毒病(COVID-19)大流行期间,前往非流行国家的旅行者中输入性传染病的趋势知之甚少。本文旨在描述前往日本的旅行者中的这些情况。
这是一项基于国家监测数据的描述性研究。输入性传染病病例定义为根据进口的可能性和影响预先选择的 15 种疾病中报告有海外感染源的病例。描述了 2016 年 4 月至 2021 年 3 月期间按疾病和诊断时间报告的传染病病例数。通过疾病比较大流行期间(2020 年 4 月至 2021 年 3 月)和大流行前期间(2016 年 4 月至 2020 年 3 月)的病例数和到达人数,计算病例数(按数量和每到达人数)的相对比值和绝对差异。
研究期间共诊断出 3524 例输入性传染病病例,其中大流行前 3439 例,大流行期间 85 例。疾病的比例分布发生了变化,但所有 15 种疾病的通知病例数在大流行期间均有所减少。然而,按到达人数计算,有七种疾病的发病率增加了一倍或更多,每百万到达人数阿米巴病(60.1;95%置信区间[CI],41.5-78.7)、疟疾(21.7;95%CI,10.5-33.0)和伤寒(9.3;95%CI,1.9-16.8)的绝对增加量显著。
大流行期间输入性传染病的流行病学发生了变化。虽然输入性传染病病例数有所减少,但在相对和绝对意义上,几种具有公共卫生和临床重要性的疾病的每到达人数病例数都有相当大的增加。